China Energy Stocks In Focus: Sinopec (386) and China Gas (384)

Sinopec's (386) and China Gas' (384) share price keep their upside momentum as indicated on the daily charts...

Uptrend 3

Sinopec (386): Rebound Intact


Source: GAIN Capital, TradingView

Chinese investment bank CICC pointed out that OPEC's decision to gradually increase crude production and positive coronavirus vaccine development have supported oil prices, and it said investors should keep an eye on undervalued Sinopec (386).

From a technical point of view, Sinopec's (386) recent rebound remains intact as shown on the daily chart. It has potentially formed a higher-low and support is provided by the 50-day moving average, which has turned upward. The level at HK$3.25 may be considered as the nearest support, while the 1st and 2nd resistance are expected to be located at HK$3.84 and HK$4.12 respectively.



China Gas (384): Extending its Rally


Source: GAIN Capital, TradingView

JPMorgan affirmed its "overweight" rating for China Gas (384), point out that the company's share price has outperformed its peers by around 4% since interim result released in late November. The investment bank expects the company's free cash flow, which turned positive in the first half of the year, to be sustainable.

From a technical point of view, China Gas (384) is gathering more upside momentum as shown on the daily chart. In fact, it has accelerated to the upside after breaking above a bullish falling wedge pattern, with the 20-day moving average rising further above the 50-day one. The level at HK$27.00 might be considered as the nearest support, while the 1st and 2nd resistance are expected to be located at HK$33.40 and HK$36.70 respectively.


More from Stocks

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.